 |
| Pictured centre: Dr Anna Schroeder and Dr Barbara Cardoso |
Dr Cardoso and Dr Schroeder received $10,000 for their collaborative project to investigate whether selenium, a naturally occurring trace element with anti-inflammatory and antioxidant properties, can prevent cognitive impairment associated with schizophrenia in a mouse model.
Dr Cardoso is a nutritional biochemist with a Masters and PhD from the University of Sao Paulo, Brazil, and has international experience obtained from research appointments in Brazil and Spain. Since receiving her PhD in 2014, Dr Cardoso has established herself as a prominent researcher in the field of selenium and has developed breakthrough studies that combine her skills in nutrition, clinical trials, analytical chemistry and molecular biology to unravel the biochemistry of selenium and its implications in Alzheimer’s disease.
Dr Schroeder’s research focuses on the mechanisms underlying cognitive function associated with schizophrenia using diverse mouse models, behavioural paradigms, and molecular analyses. Dr Schroeder earned her Master's in Neuroscience from the University of Bonn, Germany, and has a PhD in Neuroscience from the University of Melbourne.
Dr Cardoso and Dr Schroeder’s project was ranked the highest by an external review panel, with the award being presented at the recent SCS staff meeting.
“I think for me, receiving this award means opening a door to new opportunities and connections enabling us to collectively investigate a potential preventative treatment option for schizophrenia,“ said Dr Schroeder.
Dr Cardoso said, “This award is a great opportunity for cross-collaboration to further explore the impact of a dietary component in schizophrenia.”
Well done to Dr Cardoso and Dr Schroeder on this wonderful achievement.
No comments:
Post a Comment